Home › Kanser (lahat ng uri) › Hawaii › Honolulu
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Honolulu, HI
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Honolulu. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Nagre-recruitPhase 2/3
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea · 7 mi ang layo
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- at 1 pa
Connect for Cancer Prevention Study (Connect)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Kaiser Permanente Hawaii, Honolulu
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
- Hawaii Pacific Neuroscience, Honolulu
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Nagre-recruitObservasyonal na pag-aaral
- Univercity of Hawaii Cancer Center, Honolulu
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Kapiolani Medical Center for Women and Children, Honolulu
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- at 10 pa
EXoPERT EMERALD Clinical Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of Hawaii Cancer Center, Honolulu
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 2/3
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- Spark M. Matsunaga VA Medical Center, Honolulu
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Univesity of Hawaii Cancer Center, Honolulu
GEMINI-NSCLC: NSCLC Biomarker Study
Nagre-recruitObservasyonal na pag-aaral
- Hawaii Cancer Care, Honolulu
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY110 pag-aaral
- Boston, MA86 pag-aaral
- Los Angeles, CA73 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Durham, NC58 pag-aaral
- Washington, DC58 pag-aaral
- Chicago, IL51 pag-aaral
- Seattle, WA49 pag-aaral
- Atlanta, GA49 pag-aaral
- Arlington, VA48 pag-aaral
Iba pang pag-aaral sa Honolulu
- Obesity13 pag-aaral
- Kanser sa Suso12 pag-aaral
- Overweight11 pag-aaral
- Non-Small Cell Lung Cancer10 pag-aaral
- Kanser sa Baga8 pag-aaral
- Acute Myeloid Leukemia7 pag-aaral
- Type 2 Diabetes7 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Kanser sa Pancreas7 pag-aaral
- Neuroblastoma6 pag-aaral
- Kanser sa Prostate5 pag-aaral
- Burkitt Lymphoma5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.